New

Stomach Cancer Market

2021

Stomach Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy (Chemotherapy, Radiotherapy, Surgery, Targeted Therapy, Others); Healthcare Provider (Hospitals, Cancer Research Organizations, Cancer Treatment Centers) and Geography

| Report Code: TIPRE00004053 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Stomach Cancer Market 2028 By Therapy, Healthcare Provider and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Stomach cancer is also known as gastric cancer, it is caused due to the abnormal and out of control growth of the malignant cells in the stomach. This can be caused by age and food, which can increase the risk of stomach cancer. Indigestion and stomach discomfort, as well as loss of appetite, heartburn, and weight loss, are all indications of stomach cancer. Various approches are used in the treatment of stomach cancers such as, chemotherapy, radiation therapy, immunotherapy etc.

MARKET SCOPE



The "Global Stomach Cancer Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the stomach cancer market with detailed market segmentation by therapy and healthcare provider. The report provides key statistics on the market status of the leading stomach cancer market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on therapy the market is segmenetd as, chemotherapy, radiotherapy, surgery, targeted therapy and others.
  • Based on healthcare provider the market is segmented as, hospitals, cancer research organizations and cancer treatment centers.

MARKET DYNAMICS


Drivers:



  • Growing prevalences of stomach and gastrointestinal cancers along with presence of other co-morbidities are expected to boost market growth during the forecast period.
  • Growth in diagnostic and screening procedures of cancers for better treatment outlook.
  • Presence of strong pipeline of therapeutic agents is expected to spur the market growth during the forecast period.
  • Extensive R&D activities to develop novel and targeted therapies for management of stomach cancers.

Restraints:



  • However, high cost of treatment therapy along with lack of reimbursement policies are expected to restrain market growth.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The stomach cancer market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the stomach cancer market in these regions.

IMPACT OF COVID-19 ON STOMACH CANCER MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. There is big shift in demand for stomach and gastrointestinal cancer drugs and therapeutics because of pandemic situation and lockdown scenes so that people cannot come out from their homes and can't take their cancer treatments which ultimately affecting the demand for stomach cancer drugs.

MARKET PLAYERS



The report covers key developments in the stomach cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from stomach cancer market are anticipated to lucrative growth opportunities in the future with the rising demand for stomach cancer in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the stomach cancer market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Lilly
  • GlaxoSmithKline PLC
  • F. Hoffmann-La Roche Ltd
  • sanofi-aventis U.S. LLC
  • Novartis AG
  • Otsuka Holdings Co. Ltd
  • Bristol-Myers Squibb Company.
  • Pfizer,Inc
  • Merck KGaA
  • ONO PHARMACEUTICAL CO., LTD
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Stomach Cancer Market - By Therapy
1.3.2 Stomach Cancer Market - By Healthcare Provider
1.3.3 Stomach Cancer Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. STOMACH CANCER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. STOMACH CANCER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. STOMACH CANCER MARKET - GLOBAL MARKET ANALYSIS
6.1. STOMACH CANCER - GLOBAL MARKET OVERVIEW
6.2. STOMACH CANCER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. STOMACH CANCER MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. RADIOTHERAPY
7.4.1. Overview
7.4.2. Radiotherapy Market Forecast and Analysis
7.5. SURGERY
7.5.1. Overview
7.5.2. Surgery Market Forecast and Analysis
7.6. TARGETED THERAPY
7.6.1. Overview
7.6.2. Targeted Therapy Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. STOMACH CANCER MARKET - REVENUE AND FORECASTS TO 2028 - HEALTHCARE PROVIDER
8.1. OVERVIEW
8.2. HEALTHCARE PROVIDER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CANCER RESEARCH ORGANIZATIONS
8.4.1. Overview
8.4.2. Cancer Research Organizations Market Forecast and Analysis
8.5. CANCER TREATMENT CENTERS
8.5.1. Overview
8.5.2. Cancer Treatment Centers Market Forecast and Analysis

9. STOMACH CANCER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Stomach Cancer Market Overview
9.1.2 North America Stomach Cancer Market Forecasts and Analysis
9.1.3 North America Stomach Cancer Market Forecasts and Analysis - By Therapy
9.1.4 North America Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.1.5 North America Stomach Cancer Market Forecasts and Analysis - By Countries
9.1.5.1 United States Stomach Cancer Market
9.1.5.1.1 United States Stomach Cancer Market by Therapy
9.1.5.1.2 United States Stomach Cancer Market by Healthcare Provider
9.1.5.2 Canada Stomach Cancer Market
9.1.5.2.1 Canada Stomach Cancer Market by Therapy
9.1.5.2.2 Canada Stomach Cancer Market by Healthcare Provider
9.1.5.3 Mexico Stomach Cancer Market
9.1.5.3.1 Mexico Stomach Cancer Market by Therapy
9.1.5.3.2 Mexico Stomach Cancer Market by Healthcare Provider
9.2. EUROPE
9.2.1 Europe Stomach Cancer Market Overview
9.2.2 Europe Stomach Cancer Market Forecasts and Analysis
9.2.3 Europe Stomach Cancer Market Forecasts and Analysis - By Therapy
9.2.4 Europe Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.2.5 Europe Stomach Cancer Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Stomach Cancer Market
9.2.5.1.1 Germany Stomach Cancer Market by Therapy
9.2.5.1.2 Germany Stomach Cancer Market by Healthcare Provider
9.2.5.2 France Stomach Cancer Market
9.2.5.2.1 France Stomach Cancer Market by Therapy
9.2.5.2.2 France Stomach Cancer Market by Healthcare Provider
9.2.5.3 Italy Stomach Cancer Market
9.2.5.3.1 Italy Stomach Cancer Market by Therapy
9.2.5.3.2 Italy Stomach Cancer Market by Healthcare Provider
9.2.5.4 Spain Stomach Cancer Market
9.2.5.4.1 Spain Stomach Cancer Market by Therapy
9.2.5.4.2 Spain Stomach Cancer Market by Healthcare Provider
9.2.5.5 United Kingdom Stomach Cancer Market
9.2.5.5.1 United Kingdom Stomach Cancer Market by Therapy
9.2.5.5.2 United Kingdom Stomach Cancer Market by Healthcare Provider
9.2.5.6 Rest of Europe Stomach Cancer Market
9.2.5.6.1 Rest of Europe Stomach Cancer Market by Therapy
9.2.5.6.2 Rest of Europe Stomach Cancer Market by Healthcare Provider
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Stomach Cancer Market Overview
9.3.2 Asia-Pacific Stomach Cancer Market Forecasts and Analysis
9.3.3 Asia-Pacific Stomach Cancer Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.3.5 Asia-Pacific Stomach Cancer Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Stomach Cancer Market
9.3.5.1.1 Australia Stomach Cancer Market by Therapy
9.3.5.1.2 Australia Stomach Cancer Market by Healthcare Provider
9.3.5.2 China Stomach Cancer Market
9.3.5.2.1 China Stomach Cancer Market by Therapy
9.3.5.2.2 China Stomach Cancer Market by Healthcare Provider
9.3.5.3 India Stomach Cancer Market
9.3.5.3.1 India Stomach Cancer Market by Therapy
9.3.5.3.2 India Stomach Cancer Market by Healthcare Provider
9.3.5.4 Japan Stomach Cancer Market
9.3.5.4.1 Japan Stomach Cancer Market by Therapy
9.3.5.4.2 Japan Stomach Cancer Market by Healthcare Provider
9.3.5.5 South Korea Stomach Cancer Market
9.3.5.5.1 South Korea Stomach Cancer Market by Therapy
9.3.5.5.2 South Korea Stomach Cancer Market by Healthcare Provider
9.3.5.6 Rest of Asia-Pacific Stomach Cancer Market
9.3.5.6.1 Rest of Asia-Pacific Stomach Cancer Market by Therapy
9.3.5.6.2 Rest of Asia-Pacific Stomach Cancer Market by Healthcare Provider
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Stomach Cancer Market Overview
9.4.2 Middle East and Africa Stomach Cancer Market Forecasts and Analysis
9.4.3 Middle East and Africa Stomach Cancer Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.4.5 Middle East and Africa Stomach Cancer Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Stomach Cancer Market
9.4.5.1.1 South Africa Stomach Cancer Market by Therapy
9.4.5.1.2 South Africa Stomach Cancer Market by Healthcare Provider
9.4.5.2 Saudi Arabia Stomach Cancer Market
9.4.5.2.1 Saudi Arabia Stomach Cancer Market by Therapy
9.4.5.2.2 Saudi Arabia Stomach Cancer Market by Healthcare Provider
9.4.5.3 U.A.E Stomach Cancer Market
9.4.5.3.1 U.A.E Stomach Cancer Market by Therapy
9.4.5.3.2 U.A.E Stomach Cancer Market by Healthcare Provider
9.4.5.4 Rest of Middle East and Africa Stomach Cancer Market
9.4.5.4.1 Rest of Middle East and Africa Stomach Cancer Market by Therapy
9.4.5.4.2 Rest of Middle East and Africa Stomach Cancer Market by Healthcare Provider
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Stomach Cancer Market Overview
9.5.2 South and Central America Stomach Cancer Market Forecasts and Analysis
9.5.3 South and Central America Stomach Cancer Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.5.5 South and Central America Stomach Cancer Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Stomach Cancer Market
9.5.5.1.1 Brazil Stomach Cancer Market by Therapy
9.5.5.1.2 Brazil Stomach Cancer Market by Healthcare Provider
9.5.5.2 Argentina Stomach Cancer Market
9.5.5.2.1 Argentina Stomach Cancer Market by Therapy
9.5.5.2.2 Argentina Stomach Cancer Market by Healthcare Provider
9.5.5.3 Rest of South and Central America Stomach Cancer Market
9.5.5.3.1 Rest of South and Central America Stomach Cancer Market by Therapy
9.5.5.3.2 Rest of South and Central America Stomach Cancer Market by Healthcare Provider

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. STOMACH CANCER MARKET, KEY COMPANY PROFILES
11.1. LILLY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. F. HOFFMANN-LA ROCHE LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI-AVENTIS U.S. LLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. OTSUKA HOLDINGS CO. LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BRISTOL-MYERS SQUIBB COMPANY.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER,INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK KGAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ONO PHARMACEUTICAL CO., LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
The List of Companies

- Lilly
- GlaxoSmithKline PLC
- F. Hoffmann-La Roche Ltd
- sanofi-aventis U.S. LLC
- Novartis AG
- Otsuka Holdings Co. Ltd
- Bristol-Myers Squibb Company.
- Pfizer,Inc
- Merck KGaA
- ONO PHARMACEUTICAL CO., LTD
- Dr. Reddy's Laboratories Ltd
- Genentech, Inc
TIPRE00004053
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.